VeriMomlavandula angustifolia extract hamilelikte güvenli mi?
No EU Annex II/III listing or harmonised reproductive H‑code was found for Lavandula angustifolia extract (CAS 90063-37-9). Regulatory and authoritative reviews (ECHA substance entry; EMA/HMPC overview) report no major reproductive safety concerns for lavender preparations, and peer‑reviewed studies located concern skin biology or topical effects rather than developmental/reproductive toxicity. Sources: ECHA substance information; EMA HMPC overview; PubMed search found no reproductive/developmental animal data for the extract. (ECHA; EMA; PubMed).
Pregnancy-safe products containing lavandula angustifolia extract
Related ingredients
Frequently asked questions
- lavandula angustifolia extract hamilelikte güvenli mi?
- No EU Annex II/III listing or harmonised reproductive H‑code was found for Lavandula angustifolia extract (CAS 90063-37-9). Regulatory and authoritative reviews (ECHA substance entry; EMA/HMPC overview) report no major reproductive safety concerns for lavender preparations, and peer‑reviewed studies located concern skin biology or topical effects rather than developmental/reproductive toxicity. Sources: ECHA substance information; EMA HMPC overview; PubMed search found no reproductive/developmental animal data for the extract. (ECHA; EMA; PubMed).
- lavandula angustifolia extract emzirirken güvenli mi?
- No evidence in regulatory dossiers, SCCS/CIR opinions, or peer‑reviewed literature that Lavandula angustifolia extract causes reproductive or lactation-specific toxicity or transfers in amounts of concern via topical application. Major safety databases (ECHA, EWG Skin Deep) list allergy/irritancy as the primary concerns rather than lactation or developmental toxicity.
- lavandula angustifolia extract bebek cildi için güvenli mi?
- Hazard/mechanism evidence for reproductive or developmental toxicity is absent, so h/m remain 0. Exposure (e) is increased by +1 for infants because infant skin has higher permeability and the ingredient is topically applied; although the extract itself is not reported as highly systemically bioavailable, neonatal skin immaturity makes measurable absorption more likely than in adults. Primary concerns remain topical irritation/allergy rather than developmental toxicity.
- VeriMom lavandula angustifolia extract nasıl puanlıyor?
- VeriMom lavandula angustifolia extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte lavandula angustifolia extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.